Polypyrimidine tract binding protein functions as a negative regulator of feline calicivirus translation. by Karakasiliotis, I et al.
Polypyrimidine Tract Binding Protein Functions as a
Negative Regulator of Feline Calicivirus Translation
Ioannis Karakasiliotis1¤, Surender Vashist1, Dalan Bailey1, Eugenio J. Abente2,3, Kim Y. Green2, Lisa O.
Roberts4, Stanislav V. Sosnovtsev2, Ian G. Goodfellow1*
1Department of Virology, Imperial College London, London, United Kingdom, 2 Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases,
National Institutes of Health, Bethesda, Maryland, United States of America, 3Department of Cell Biology and Molecular Genetics, University of Maryland, College Park,
Maryland, United States of America, 4 Faculty of Health and Medical Sciences, University of Surrey, Guildford, United Kingdom
Abstract
Background: Positive strand RNA viruses rely heavily on host cell RNA binding proteins for various aspects of their life cycle.
Such proteins interact with sequences usually present at the 59 or 39 extremities of the viral RNA genome, to regulate viral
translation and/or replication. We have previously reported that the well characterized host RNA binding protein
polypyrimidine tract binding protein (PTB) interacts with the 59end of the feline calicivirus (FCV) genomic and subgenomic
RNAs, playing a role in the FCV life cycle.
Principal Findings: We have demonstrated that PTB interacts with at least two binding sites within the 59end of the FCV
genome. In vitro translation indicated that PTB may function as a negative regulator of FCV translation and this was
subsequently confirmed as the translation of the viral subgenomic RNA in PTB siRNA treated cells was stimulated under
conditions in which RNA replication could not occur. We also observed that PTB redistributes from the nucleus to the
cytoplasm during FCV infection, partially localizing to viral replication complexes, suggesting that PTB binding may be
involved in the switch from translation to replication. Reverse genetics studies demonstrated that synonymous mutations in
the PTB binding sites result in a cell-type specific defect in FCV replication.
Conclusions: Our data indicates that PTB may function to negatively regulate FCV translation initiation. To reconcile this
with efficient virus replication in cells, we propose a putative model for the function of PTB in the FCV life cycle. It is possible
that during the early stages of infection, viral RNA is translated in the absence of PTB, however, as the levels of viral proteins
increase, the nuclear-cytoplasmic shuttling of PTB is altered, increasing the cytoplasmic levels of PTB, inhibiting viral
translation. Whether PTB acts directly to repress translation initiation or via the recruitment of other factors remains to be
determined but this may contribute to the stimulation of viral RNA replication via clearance of ribosomes from viral RNA.
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Introduction
The regulation of mRNA translation by RNA-binding proteins
is an essential mechanism for the control of gene expression. RNA-
binding proteins form functional ribonucleoprotein complexes
(RNPs) that determine the fate of the cognate mRNAs. They have
been shown to play crucial roles in RNA metabolism, such as pre-
mRNA splicing, capping and polyadenylation, tRNA maturation,
mRNA localization and translation, which in turn affect the vast
majority of cellular processes.
Polypyrimidine tract binding (PTB) protein, one of the best
studied RNA-binding proteins, is a 57 kDa protein with four RNA
recognition motifs (RRMs) and an affinity for pyrimidine-rich
RNA sequences [1]. The interaction of the individual RRMs with
different sites on the same RNA, often distant in terms of their
nucleotide position in the primary sequence, can result in
substantial restructuring of the RNA in order to adopt a
‘‘functional conformation’’ [2,3]. This RNA chaperone activity
of PTB is well documented and is known to be important for the
life cycle of many viruses [4]. PTB has a primarily nuclear
localization but is has been demonstrated that specific signals, such
as PKA phosphorylation [5], viral infections [6] or alterations in
nuclear pore permeability [7], may lead to its translocation to the
cytoplasm. Nuclear PTB is a negative regulator of pre-mRNA
alternative splicing [8] and in some cases regulates mRNA
polyadenylation [9]. Cytoplasmic PTB affects a-actin mRNA
localisation in neurites, while the Xenopus homologue of PTB
regulates Vg1 mRNA localisation [10]. One extensively studied
role of cytoplasmic PTB is in the regulation of IRES-dependent
translation of several cellular and viral mRNAs. PTB is required
for the IRES-dependent translation of Bag-1, Apaf-1 and p53
mRNAs [2,3,11] and it is also required for the efficient function of
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the poliovirus (PV) [12], foot-and-mouth disease virus (FMDV)
[13] and Theiler’s murine encephalomyelitis virus (TMEV) [14]
IRES elements. A context-dependent requirement of PTB has also
been described for encephalomyocarditis virus (EMCV) transla-
tion [15]. While a role for PTB in HCV IRES function has been
proposed, the exact function in this context is still rather unclear
[16,17,18]. In some cases (e.g. Dengue virus) PTB regulates viral
replication rather than translation [19,20]. Using translation-
deficient defective interfering murine hepatitis virus (MHV) RNAs
it was also shown that PTB is required for MHV replication [21].
The Caliciviridae family of positive-strand RNA viruses is divided
into four currently defined genera: Norovirus, Sapovirus, Lagovirus and
Vesivirus. Human caliciviruses (HuCV), from the Norovirus and
Sapovirus genera are a major cause of acute gastroenteritis and are
responsible for more than 85% of non-bacterial gastroenteritis
outbreaks in Europe [22]. Despite recent advances no suitable and
efficient cell culture system is, as yet, available for the propagation
of HuCVs in vitro [23,24,25,26]. In contrast, feline calicivirus
(FCV) and murine norovirus (MNV) can be efficiently propagated
in conventional tissue culture and are readily used as models for
the study of molecular mechanisms that regulate the life cycle of
caliciviruses [27]. The FCV genome of 3 open reading frames
(ORFs, Fig 1); ORF1 is translated from the genomic RNA (gRNA)
producing the non-structural proteins (NS1, NS2, NS3, NS4, NS5
and NS6-7), while ORF2 and ORF3, encoding the major and
minor capsid proteins (VP1 and VP2 respectively) are expressed
from a subgenomic RNA (sgRNA) produced during infection [28].
Calicivirus protein synthesis is thought to occur via a unique
mechanism not found in any other animal RNA viruses. This
mechanism relies on ribosomal recruitment by the VPg (NS5)
protein, which is covalently linked to the 59 end of the viral RNA,
through the interaction of VPg with various translation initiation
factors [29,30,31,32,33]. During our previous studies we demon-
strated a specific interaction of PTB with the 59extremity of the
FCV gRNA and sgRNA, and also the requirement for PTB in the
FCV replication cycle [34]. In the present report we have further
characterized the interaction between PTB and the FCV genome,
identifying the binding site of PTB at the 59 end of the gRNA
and demonstrating that PTB functions as a repressor of FCV
translation. We believe this represents a new mechanism to
promote the switch from translation to replication of a positive-
strand RNA virus and therefore represents a novel function for the
PTB protein.
Materials and Methods
Materials
FCV, strain Urbana, was generated by transfection of RNA
transcripts derived from the full-length infectious clone pQ14 [35]
into Crandell–Reese feline kidney (CRFK) cells obtained from
ATCC. Antisera to the FCV RNA polymerase NS6-7 (p76) were
produced as described in Karakasiliotis et al. 2006 [34]. Antisera
for western blot to hnRNP I (PTB) was purchased from Santa
Cruz Biotechnology, mouse monoclonal antibodies to PTB DH7
and DH17 were kindly provided by Eckard Wimmer (Stony
Brook University, New York, USA). Antiserum to GAPDH was
purchased from Ambion. Antiserum to FCV Urbana capsid (VP1)
was as previously described [35] .
Protein Purification
For the purification of his-PTB SG13009 E. coli cells were
transformed with a pQE9 plasmid expressing his-PTB1 provided
by Stephen Curry (Imperial College, London). The protein
purification was performed using Ni-NTA (Qiagen) according to
the manufacturer’s instructions. His-PTB was dialyzed against 50
mM HEPES pH 7.6, 1 mM DTT, 1 mM MgCl2 and 20%
glycerol. GST-PTB was purified from DH5a E. coli cells
transformed with the pGEX6P-1 PTB plasmid, provided by
Richard Jackson (University of Cambridge, UK). Cells were grown
in LB at to an OD600 of 0.6, isopropyl-b-D-thiogalactopyranoside
(IPTG) was added (0.1 mM final) and the protein expression was
allowed to occur for 2 hours. The cells were then lysed using a
French press in PBS containing 0.5 mM DTT, 10 mM EDTA,
3 mg/ml leupeptine and pepstatin, 1% Triton X-100, 1 mM
PMSF. GST-PTB was then purified from the clarified lysate using
glutathione-sepharose, washing with PBS containing 0.5 mM
DTT, 10 mM EDTA and 1% Triton X-100. A second wash
with 50 mM Tris pH 8.0, 150 mM NaCl and 0.5 mM DTT
followed and the protein then eluted in 10 mM reduced
glutathione, 50 mM Tris pH 8.0, 150 mM NaCl and 0.5 mM
DTT. Eluted protein was dialyzed against 50 mM HEPES
pH 7.6, 1 mM DTT, 1 mM MgCl2 and 20% glycerol and stored
at 280uC until further use.
Mutagenesis and Reverse Genetics Recovery
Mutagenic oligonucleotides were synthesized and used for site
directed mutagenesis of the full-length infectious clone pQ14 [35]
(primer details available upon request). Generated cDNA
constructs were sequenced in their entirety prior to virus recovery.
Wild type and mutant viruses were recovered by transfection of
CRFK cells with capped, in vitro transcribed RNA derived from
the full-length cDNA clones using Lipofectamine 2000 (Invitro-
gen). High titre virus stocks were prepared by an additional
passage in CRFK cells and viral titers were determined by
TCID50. RT-PCR was used to confirm the virus stocks retained
the introduced mutations.
Growth Kinetics Analysis
Growth curves of wild type and mutant virus (mBS2+3) were
performed in AK-D (feline fetal lung, obtained from ATCC), CRFK
(feline kidney cell line, obtained from ATCC) and FEA (feline
embryonic airway, obtained from Alan Radford, University of
Liverpool) cells to assess viral growth kinetics. Cells were plated in 24
Figure 1. Schematic representation of the feline calicivirus genome. Diagrammatic illustration of the three open reading frames present
within the feline calicivirus genome. The mature components of ORF1 are highlighted along with the recently proposed NS1-7 nomenclature used for
murine norovirus [64]. The positions of the leader of the capsid protein (LC), as well as the major and minor capsid proteins (VP1 and VP2) are also
highlighted.
doi:10.1371/journal.pone.0009562.g001
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well plates at a density of 26105cells/well. Single step growth curves
were performed using an initial multiplicity of infection (m.o.i.) of 3
TCID50 per cell, based on the titre in CRFK cells. Samples were
taken in triplicate for TCID-50 titration at 0, 4, 6, 8, 10 and 12 hours
post infection (hpi). Multi-step growth curve analysis was performed
using a m.o.i. of 0.01 and harvesting at 0, 4, 8, 12, 24 and 28 hpi.
In Vitro Translation Assays
FCV VPg-linked RNA was purified from FCV replication
complexes isolated from FCV infected CRFK cells as described
previously [31]. The 59cap-CAT-FMDV IRES-Luc dicistronic
RNA was produced by T7 in vitro transcription from the dicistronic
plasmid pGEM-CAT/FMDV/LUC [36]. The dicistronic RNA
was polyadenylated using E.coli Poly(A) polymerase (Ambion). The
FCV 59G1–245 RNA was produced by PCR using primers which
introduced a T7 RNA polymerase promoter at the 59 end of the
PCR product (details available upon request) followed by in vitro
transcription. The in vitro translation assays were performed in
Flexi rabbit reticulocyte lysates (RRLs) (Promega). Each 12.5 ml
translation reaction included 6.25 ml of RRL, 20 mM amino acid
mixture minus methionine, 100 mM KCl, 2 mM DTT, 0.5 mM
MgOAc, 5 mCi 35S methionine (1000 Ci/mmol) (GE Healthcare)
and 312.5 ng of an RNA preparation containing FCV VPg-linked
RNA or in vitro transcribed dicistronic RNA. Translation reactions
occasionally contained 1 ml of his-PTB at various concentrations,
and 59G1-245 RNA transcripts at various concentrations. The
reactions were incubated at 30uC for 1.5 h.
Biochemical Structure Probing
Biochemical RNA structure probing was performed using the
conformational specific RNases V1, A, T1 (Ambion) and T2
(MoBiTec GMBH). In vitro transcribed, gel purified and refolded
RNA (1 mg) was mixed with yeast RNA (1 mg) and structure buffer
provided with the RNases (Ambion). Enzymatic cleavage reactions
were performed at 30uC for 10 minutes with enzyme concentra-
tions empirically determined to generate single cleavage products.
The reactions were stopped using inactivation/precipitation buffer,
the RNA precipitated, subsequently washed with 70% ethanol and
resuspended in 10 ml of nuclease free water. An aliquot of the
digested RNA (2 ml) was then used for primer extension with end
labeled primers and AMV reverse transcriptase as described by the
manufacturer (Promega). A sequencing ladder generated using the
same primer was run along with the primer extension products on a
7M urea 6% acrylamide sequencing PAGE. The gel was dried and
exposed to a phosphorimager screen.
Electrophoretic Mobility Shift (EMSA) Assays
Radioactive probes were generated by in vitro transcription of
PCR products containing the region of interest under the control
of a T7 RNA polymerase promoter (primer details available upon
request). Radioactively labeled RNA was subsequently gel purified
by denaturing urea PAGE, the probe excised, eluted and
precipitated prior to quantification by spectrophotometry. RNA
was refolded by heat denaturation followed by slow annealing
(,1uC/min) prior to use. Typically a 7.5 ml EMSA reaction
contained 85 nM radioactive RNA probe, GST-PTB at various
concentrations (see figures for more details), 0.67 mg/ml yeast
tRNA (Ambion), 50 mM HEPES pH 7.6, 25 mM KCl, 2.5 mM
MgCl2, 1 mM DTT and 4% glycerol. All reactions were
incubated for 10 min at 30uC and the reactions analyzed on a
4% acrylamide gel (acrylamide:bis-acrylamide 19:1) containing
5% glycerol. The EMSA gels were dried and visualized on a
phosphorimager screen. Band quantification was performed using
the ImageQuant 5.0 software package (Molecular Dynamics) and
the amount of protein required to shift 50% of the probe was
determined using SigmaPlot. Note that relative, rather than
absolute, affinity was determined due to the difficulty in
determining the active fraction of the purified GST-PTB.
RNase H Mediated Inactivation of VPg-Linked FCV
Genomic RNA
The specific digestion of the FCV genomic RNA in the viral
RNA preparation from infected cells was carried out using RNase
H and an oligonucleotide that is complementary to NS6-7 coding
region (ntds positions 3215-3244). RNase H reactions contained
1.26 mg of VPg-linked RNA preparation, 25 pmol of primer, 10 U
RNAsin (Promega), 37.5 mM KCl, 25 mM Tris-HCl pH 8.3,
1.5 mM MgCl2, 5 mM DTT and 50 U of RNase H (Ambion).
The reaction was incubated at 37uC for 20 min. M13/Puc R was
used as non-specific control oligonucleotide to control for any
effects of RNase treatment and subsequent extraction on the
replication/translation of the viral RNA.
Confocal Microscopy Analysis of PTB Localization
CRFK cells were plated on round glass cover slips and infected
with FCV (m.o.i. of 0.5) for 16 h at 32uC . The glass cover slips
were washed with chilled PBS and fixed in 4% paraformaldehyde
solution containing 250 mM HEPES pH 7.4 for 10 min on ice.
An 8% paraformaldehyde solution containing 250 mM HEPES
pH 7.4 was applied for 20 min at room temperature and the cells
were washed 3 times in PBS. 50 mM ammonium chloride was
applied for 10 min at room temperature and the cells were washed
3 times in PBS. Permeabilization of the cells was achieved using
0.2% Triton-X 100 in PBS for 10 min at room temperature
followed by three 5-minute washes in block buffer (1% bovine
serum albumin in PBS). NS6-7 staining was performed using a
rabbit polyclonal antibody and PTB staining was performed using
a mouse monoclonal antibody for PTB (DH17). Image-iT FX
signal enhancer was applied according to the manufacturer’s
instructions (Invitrogen). a-rabbit Alexa Fluor 488 (Invitrogen) and
a-mouse Alexa Fluor 546 (Invitrogen) were used as secondary
antibodies. The cover slips were mounted on a glass slide with
40 ml of Mowiol 4–88 (Calbiochem) containing 1 mg/ml of DAPI.
The cells were viewed under a Zeiss LSM 510 Meta confocal
microscope, and the images were processed with Zeiss Meta 510
software. For the quantification of staining intensity in specific
areas of the confocal images Image Quant 5.0 software (Molecular
Dynamics) was used as described previously [37]. To examine the
steady state localization of PTB in the FEA, CRFK and AK-D
cells, cells were plated, left untreated then subsequently fixed and
stained as described above, except that goat a-mouse Alexa Fluor
488 (Invitrogen) was used to detect binding of the PTB
monoclonal antibody. Live time-lapse fluorescence microscopy
was employed to monitor changes in the PTB protein localization
in FCV-infected CRFK cells. CRFK cells (26106) grown on glass
chamber slides were transfected with the pEGFP-PTB (kindly
provided by Chris Smith, Cambridge) or a combination of
pEGFP-PTB and pDsRed2-Nuc (Clontech). 24 hrs post transfec-
tion, cells were then infected with either FCV-LC-DsRed [38] or
with FCV Urbana using an m.o.i. of 2. The inoculated cells were
then transferred to an environmental chamber (37uC and 5%
CO2), and time-lapse imaging was performed using a Leica SP5
X-WLL confocal microscope (Leica, Germany). Images were
taken every five minutes, with channel (GFP and DsRed2) data
collected independently. Sequences of the confocal images were
transformed into time-lapse movies using Imaris software (version
6.4, Bitplane AG, Zurich, Switzerland).
Calicivirus Translation
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RNA Immunoprecipitation
107 CRFK cells were infected with FCV for 6 h using an m.o.i. of
0.1. Ribonucleoprotein complexes were extracted from FCV infected
CRFK cells and subjected to immunoprecipitation following the
previously described procedure [39]. DH7 and DH17 mouse
monoclonal antibodies were used for the immunoprecipitation of the
RNAs bound to PTB. NS6-7 and GAPDH specific antisera were used
as positive and negative controls respectively.
Results
Biochemical Structure Determination of the 59 Extremity
of the FCV Genome
During our previous analysis of the interaction of PTB with the
FCV genome, we demonstrated that bacterially expressed recom-
binant GST tagged PTB can bind in a sequence specific manner to
nucleotides (ntds) 1-245 and 1-284 of the 59 ends of the FCV gRNA
and sgRNA, respectively [34]. Sequence analysis demonstrated that
the 59 end of the gRNA contains 4 regions which match the PTB
binding site consensus previously identified (UCUU) [40,41] (BS1-4
in Fig 2a). To better define the role of PTB in the FCV life cycle and
to allow the generation of mutations which did not result in large
scale disruption of the RNA secondary structure, we first
determined the structure of the 59 end of the FCV genomic RNA
using ribonuclease (RNase) digestion. This analysis uses RNases
specific for either single-stranded (T1, T2 or A) or double-stranded
(V1) RNA to determine the solution structure of a particular
transcript. This type of analysis has to date, not been undertaken on
the 59 end of a genome for any member of the Caliciviridae family.
RNase cleavage sites were determined using primer extension with
two different primers (Fig 2b and c) and then mapped onto a
structure predicted using the MFold software [42] (Fig 2a). Clearly
Figure 2. Sequence and structure of the 59 end of the feline calicivirus genome. (A) RNA sequence of nucleotides 1-245 of the feline
calicivirus genomic RNA, highlighting the four potential PTB binding sites (BS1-4). Note that the pyrimidine rich sequences around the core PTB
binding sequence (UCUU) are highlighted. The ORF1 AUG initiation codon at position 20 is shown in bold italics. The positions of single strand
specific RNases T1,T2 and A, as well as the double-strand specific RNase V1, obtained from RNase sensitivity mapping (shown in panel B and C) are
highlighted as detailed in the symbol legend. (B) In vitro transcribed RNA representing nucleotides 1-245 of FCV genomic RNA was subjected to
limited RNase digestion and primer extension analysis using either a primer binding between nucleotides 223 to 204 (B) or nucleotides 245–228 (C). A
sequencing ladder was generated using same primers and run on the gel along with primer extension products to identify the cleavage sites of
RNases. The positions of RNase cleavage sites which show disparity with the predicted RNA structure are highlights with a black filled circle. Note that
only cleavage sites which were apparent in multiple experiments are depicted.
doi:10.1371/journal.pone.0009562.g002
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defined regions of single- and double-stranded RNA were observed
and in the majority of cases the predicted structure was confirmed.
However a limited number of regions showed some disparity
(highlighted in Fig 2a); for example G57 is predicted to form a G-U
interaction with U72, however a clear T1 RNase cleavage site was
obtained. In addition C93 is predicted to lay within a single-
stranded loop sequence, and indeed positions G90 and U91 were
found to be single-stranded, however clear RNase V1 cleavage was
obtained at position 93 (Fig 2b and c). The positions displaying
disparity are likely the result of flexibility or ‘‘breathing’’ often
observed in RNA structures and/or additional tertiary RNA-RNA
interactions which occur and which are not detected using standard
structure predictions.
PTB Binds to at Least Two Sites in the 59 End of the FCV
Genomic RNA
To further characterize the interaction between PTB and the 59
end of the FCV gRNA, truncations of the region were used as
radiolabeled probes for EMSA analysis (Fig 3). The predicted PTB
consensus binding sequences (BS1-BS4, Fig 2a) were taken into
consideration during the design of the truncations (Fig 3a) in order
to analyze the relative contribution of the potential binding sites to
PTB binding. Also, to minimize the effect of RNA truncations on
the overall folding of the RNA transcripts, the secondary structure
of the region, as determined biochemically (Fig 2a) was also taken
into account. Two sets of truncations were tested for their ability to
form a complex with GST tagged PTB by EMSA analysis. The
FCV 59 end probe encompassing ntds 1-245 was truncated at the
39 end producing RNA transcripts containing ntds 1–111, 1–163
and 1–202 as illustrated in Fig 3a. Ntds 1–111 did not contain any
of the PTB consensus sequences, 1–163 encompassed the potential
binding sites BS1 and BS2, with the 1–202 sequence containing
the BS1, BS2 and BS3 consensus sequences. Truncations from the
59 end were also generated to produce RNA transcripts that
encompassed ntds 32–245, 118–245 and 128–245 (Fig 3a). Ntds
32–245 contained all predicted PTB consensus sequences, but
Figure 3. Identification of PTB binding sites using truncation analysis. EMSA analysis of GST-PTB binding to probes encompassing various
regions of the FCV 59 end. Radiolabeled RNA probes were generated by in vitro transcription of PCR products encompassing the various regions of
the FCV genome, followed by gel purification. EMSA reactions were set up as described in the text and the reactions analyzed by native PAGE. Gels
were then dried, exposed to phosphorimager screen and the amount of probe in a complex with PTB determined using ImageQuant software. (A)
Diagrammatic representation of the truncations under study highlighting the relative affinity of PTB for the transcript. # highlights that the affinity is
expressed relative to WT 1–245 probe (set at 1). nd denotes that the relative affinity could not be determined due to insufficient complex formation.
EMSA gels using the 1–245 transcript along with the 39 end truncations (B) or 59 end truncations (C). EMSAs were performed a minimum of three
times and the data obtained from one representative experiment shown. Asterisks are used to highlight the position of alternative conformations of
the RNA probe which make up a minor component of the refolded RNA transcript.
doi:10.1371/journal.pone.0009562.g003
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lacked the first stem loop at the 59 end, nts 118–245 encompassed
BS2, BS3 and BS4 potential binding sites and ntds 128–245
contained BS3 and BS4 consensus sequences (Fig 2a). Bioinfor-
matic analysis indicated that the truncations did not have any
detrimental effect to the overall structure adopted by the RNA or
the structural context of the potential PTB binding sites (data not
shown).
As expected, PTB was unable to bind to the transcript 1–111,
containing none of the predicted PTB binding sites (Fig 3a and b).
Addition of the first two potential binding sites (BS1 and BS2), in the
transcript 1–163, dramatically increased the ability of PTB to bind
(Fig 3a and b). The further addition of BS3, using the transcript
1–202, restored the relative affinity of the RNA for PTB to the levels
observed using ntds 1–245 level (Fig 3a and b). Deletion of the first
31 ntds from the 59 end of the 1–245 transcript, which removes the
entire first stem loop (Fig 2a) producing the transcript 32–245, did
not disrupt PTB binding whereas the deletion of the first 117 ntds,
removing BS1 (as in the 118–245 probe), led to a significant
reduction in PTB binding (Fig 3a and c). The additional deletion of
BS2, producing the transcript 128–245, resulted in the almost
complete loss of PTB binding (Fig 3a and c). These data indicated
that sequences around BS1, BS2 and BS3 contribute to PTB
binding (compare binding to 118–245 and 1–163 with 1–202, Fig 3a
and c). It was evident that ‘‘spatial context’’ in which BS2 and 3 are
present also plays a role as the transcript 118–245, containing both
BS2 and 3 displayed a reduced ability to bind PTB (compare 118–
245 with 1–245 Fig 3a and c).
Mutation of BS2 and BS3 Reduces PTB Binding to the 59
End of the FCV Genome
To clarify the contribution of the other potential binding sites,
mutations were introduced in order to disrupt the PTB consensus
binding sequence in BS1, BS2 and BS3 in all possible
combinations (Fig 4a). As all the potential binding sites were
Figure 4. Identification of PTB binding sites using synonymous mutations. EMSA analysis of GST-PTB binding to wild type (WT) or mutant
derivatives of nucleotides 1–202 of the FCV 59 end. Radiolabeled RNA probes were generated by in vitro transcription of PCR products, followed by
gel purification. EMSA reactions were set up as described in the text and the reactions analyzed by native PAGE. Gels were then dried, exposed to
phosphorimager screen and the amount of probe in a complex with PTB determined using ImageQuant software. (A) Diagrammatic representation of
the region under study highlighting the binding sites (BS1-3), the mutations introduced (m) are underlined and the amino acid sequence coded by
that region of the genome is also shown. The relative affinity of PTB for the transcript is shown based on quantification of PTB binding. # highlights
that the affinity is expressed relative to WT 1–202 probe. (B) Quantification of PTB binding to WT or PTB binding site mutants (mBS1-3). The amount
of radiolabeled probe in a complex with PTB was determined using phosphoimager and expressed as a percentage of the total. Note that for clarity
only data for the single binding site mutant BS3 (mBS3) is shown but mBS1 and mBS2 displayed identical binding curves (data not shown). (C)
Representative EMSA gel displaying the binding of GST-PTB to WT RNA probe or a probe containing synonymous changes in binding sites 1, 2 and 3
(mBS1+2+3). EMSAs were performed a minimum of three times and the data obtained from one representative experiment shown.
doi:10.1371/journal.pone.0009562.g004
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located in the protein-coding region, the mutations were designed
to preserve the original amino-acid sequence (synonymous
nucleotide changes) while altering the pyrimidine rich sequence
in order to allow subsequent analysis of their effects on virus
replication (detailed below). All mutations were generated in a
probe encompassing ntds1–202 as our data indicated that this
probe contained all the necessary sequences required for efficient
PTB binding (Fig 3). The mutation of individual binding sites
showed no effect on PTB binding (data not shown, Fig 4a and b).
The triple binding site mutant mBS1+2+3, containing synony-
mous changes in all three potential binding sites, showed a
dramatic reduction in PTB binding (Fig 4) while the only double
mutant that demonstrated similar defects in PTB binding was
mBS2+3 (Fig 4a and b). As the PTB binding curve for the mBS2+3
mutant was the same as the triple mutant, it was concluded that
the minimum combination of mutations required to reduce PTB
binding were in BS2 and 3. Clearly, although mutation of BS2 and
3 reduced PTB binding, some residual binding activity remained
(Fig 4). This suggested that either additional sequences contributed
to PTB binding or that the introduced synonymous changes,
which do not remove all pyrimidines within the binding sites, are
not sufficient to completely disrupt PTB binding. To address this,
the mutational analysis was extended using RNAs in which the
polypyrimidine tracts of BS1, 2 and 3 were fully substituted for
adenines (full(A) mutant). PTB binding of the full(A) mutant RNAs
was identical to that observed for the synonymous mutations,
showing that the residual binding observed for the synonymous
mutant RNAs was not due to remaining pyrimidines in the
potential binding sites (data not shown).
PTB Translocates from the Nucleus to the Cytoplasm
during FCV Infection
To begin to determine the role that PTB plays in the FCV life
cycle we first examined how virus infection altered PTB
localization. Infected CRFK cells were stained for PTB and the
viral polymerase, NS6-7, as a marker for the viral replication
complexes. The localization of PTB in uninfected cells is
predominantly nuclear (Fig 5a). We observed that during FCV
infection of CRFK cells at 37uC PTB remained predominantly
nuclear at all stages of infection, while only a small fraction of
infected cells, typically those expressing high levels of NS6-7,
demonstrated an increase in the cytoplasmic portion of PTB (data
not shown). At 32uC however, the temperature at which we have
previously shown PTB to play a more apparent role in the viral life
cycle in CRFK cells [34], this observed effect of FCV infection on
PTB localization was more dramatic and infected cells demon-
strated decreased nuclear and increased cytoplasmic PTB levels
(Fig 5a). Quantification of staining intensity from 25–40 infected
cells, demonstrated a noticeable correlation between the levels of
the NS6-7 protein present in a cell and the extent to which PTB
has been redistributed to the cytoplasm (Fig 5b and c). Increased
levels of NS6-7 in the cytoplasm of the infected cell correlated with
Figure 5. Feline calicivirus infection results in the redistribution of PTB. CRFK cells were infected with FCV for 16 h at 32uC and at an m.o.i.
of 0.5 (A) Infected and control cells were fixed and stained for NS6-7 (green) and PTB (DH17 monoclonal, red). DAPI was used for nuclei (blue)
staining. The cells were observed using confocal microscopy. Quantification of nuclear (B) and cytoplasmic (C) PTB density (arbitrary intensity units/
arbitrary volume units) against the density of NS6-7 in the cytoplasm of the same cell. Individual NS6-7 expressing cells were selected and a region of
interest selected in the cytoplasm and nucleus. The levels of NS6-7 staining (green) and PTB staining (red) was quantified in arbitrary units and
plotted accordingly (see materials and methods for further details).
doi:10.1371/journal.pone.0009562.g005
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decreased levels of nuclear PTB and increasing levels of
cytoplasmic PTB (Fig 5b and c). This observation indicated that
as infection progresses, PTB is redistributed from the nucleus to
the cytoplasm. This was further verified by examining the
localization of a GFP-PTB fusion protein during the course of
FCV infection using time-lapse image analysis (Fig 6a and
supplementary Figure S1). CRFK cells expressing GFP-PTB were
infected with a recombinant FCV expressing a LC-DsRED fusion
protein as described [38]. As infection progressed, evident by the
appearance of LC-DsRED, clear relocalization of GFP-PTB
occurred (Fig 6a). To examine if the observed effect was a global
effect on nuclear-cytoplasmic localization or a more specific effect
on PTB localization, cells expressing GFP-PTB and DsRED2
fused to 3 copies of the nuclear localization sequence of the SV40
large T-antigen (DsRED2-Nuc), were infected with FCV and
examined by time-lapse microscopy (Fig 6b and supplementary
Figure S2). The progress of infection resulted in a gradual increase
of the cytoplasmic fraction of the PTB protein starting from 7.5
hpi. Similar to the time-lapse experiments with FCV-LC-DsRED
virus, a significant release of the PTB was observed , at 13 hpi,
1.5 hours prior to relocalization of DsRED2-Nuc (Supplementary
Figure S2).
PTB Partially Localizes with FCV Replication Complexes
and Interacts with Viral RNA during Infection
Feline calicivirus replication occurs within the replication
complexes formed in the cytoplasm [43]. A larger magnification
of the cytoplasm of infected cells indicated that PTB at least
partially colocalized with the NS6-7 protein within the replication
complexes (Fig 7a). Quantification of NS6-7 and PTB intensity on
a linear section of the image revealed that colocalization was more
apparent in regions of the cytoplasm containing higher NS6-7
intensity (presumably more mature) replication complexes,
revealing a possible link between cytoplasmic PTB and replication
complex maturation (see highlighted replication complex in Fig 7a
and b). Alternatively, it may simply reflect limited accessibility of
the mAb epitope to PTB within a proportion of the membrane
bound replication complexes. Although our in vitro data demon-
strated efficient PTB binding to the FCV genome, it was
important to demonstrate that this interaction also occurred
during viral infection. To address this question, RNA immuno-
precipitation was used to determine if PTB was physically
associated with the viral RNA during replication. Two monoclonal
antibodies (DH7 and DH17) to PTB that efficiently immunopre-
cipitated PTB from cell extracts (data not shown) were able to co-
precipitate the FCV RNA from infected CRFK cells as
determined by RT-PCR (Fig 7c). A polyclonal antibody against
the viral protease-polymerase, NS6-7, was used as a positive
control, while a monoclonal antibody against GAPDH was unable
to co-immunoprecipitate the viral RNA, confirming the specificity
of the interaction (Fig 7c).
PTB Inhibits FCV Translation In Vitro
In order to define the stage of the virus life cycle at which PTB
might be involved, the uncoupling of the two main processes,
translation and replication, was required. These two processes are
inherently linked for all positive-strand RNA viruses since the viral
RNA functions both as a template for replication by the RNA
polymerase and as a template for translation. In addition, the
unique mechanism of calicivirus VPg-dependent calicivirus
translation initiation which relies on the interaction of host cell
translation initiation factors with the VPg protein covalently linked
to the 59 end of viral RNA [29,30,31], precludes the use of in vitro
transcribed RNA for the study of authentic virus translation and
replication. However, we have recently developed an in vitro
translation system [31], which allows some aspects of calicivirus
translation initiation to be characterized in the absence of genome
replication. As PTB is a well known regulator of picornavirus
translation [13] its effect on FCV translation was assessed by
titration of recombinant his-PTB in a rabbit reticulocyte lysate
(RRL) FCV in vitro translation assay (Fig 8). Addition of increasing
amounts of PTB resulted in a decrease in the production of in vitro
synthesized 35S-labeled FCV proteins (Fig 8a), indicating that PTB
may function as a negative regulator of calicivirus translation
initiation. To confirm that the observed effect was specific for the
interaction of PTB with the FCV genome, in vitro transcribed RNA
encompassing the FCV genome from ntds1-245 (59G1-245) was
titrated back into reactions containing inhibitory levels of
recombinant PTB (Fig 8a). FCV translation was restored back to
WT levels when exogenous FCV 59G1–245 RNA was added to the
reaction, confirming the specificity of the effect. A 59end capped
and 39 polyadenylated dicistronic RNA expressing the CAT
enzyme in a cap-dependent manner and firefly luciferase under
the control of the FMDV IRES (59cap-CAT:FMDV-IRES-Luc-
p(A)) was used to assess the effects of PTB on the general cap-
dependent and IRES-dependent translation (Fig 8b). Upon
addition of low amounts of PTB into the translation reactions
cap-dependent translation was not affected, while FMDV
translation demonstrated a slight increase (Fig 8b). Under the
same conditions, FCV translation was reduced by 40 and 60%
when 70 ng and 140 ng of PTB was added to the translation
reactions respectively (Fig 8a). At the highest concentration of PTB
both the FMDV IRES dependent and cap dependent translation
were slightly inhibited (Fig 8b). In contrast to FCV translation,
titration of the 59G1-245 RNA transcript into reactions containing
280 ng of PTB, did not restore the levels of either cap-dependent
or FMDV IRES-dependent translation. Therefore it is possible
that the observed inhibitory effect on cap and IRES-dependent
translation may be the due to contaminating factor(s) co-purified
with PTB from E.coli, rather than PTB itself. Alternatively the
FCV G1–245 sequence may be unable to compete for PTB binding
to the dicistronic RNA or high levels of PTB may have resulted in
competition for other factors required for general translation
initiation in the RRL.
FCV Translation Is Enhanced by RNAi-Mediated
Knockdown of PTB
As stated above, the requirement for the covalent linkage of the
virus encoded VPg protein to the 59end of FCV RNA for efficient
translation excludes the use of in vitro transcribed RNA for the study of
authentic calicivirus translation initiation. During virus replication a
sgRNA is produced from the 39 half of the viral genomic RNA,
which, similarly to the genomic RNA, is translated following the
recruitment of translation initiation factors by the VPg protein.
However, the sgRNA does not produce the viral polymerase and
encodes only the major capsid precursor protein (LC-VP1) and the
minor capsid (VP2) protein. Thus, transfection of cells with VPg-
linked sgRNA alone allows the analysis of virus translation in the
absence of replication as there is no source of the NS7 RNA
polymerase. We have previously demonstrated that PTB also binds
the 59 end of the sgRNA [34], therefore as an attempt to separate the
two major processes of the FCV life cycle, namely translation and
replication, was made by specific digestion and functional inactivation
of the genomic RNA within VPg-linked RNA preparations using
DNA oligonucleotide-directed RNase H mediated digestion. A DNA
oligonucleotide complementary to the coding region of the protease-
RdRp (NS6-7) was annealed to the viral RNA preparation and the
complex was digested by the DNA:RNA hybrid specific RNase H
Calicivirus Translation
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Figure 6. Feline calicivirus infection causes both PTB specific and general effects on nuclear localization of proteins. (A). GFP-PTB
expressing CRFK cells were infected with recombinant FCV expressing a LC-dsRED fusion protein (m.o.i. 2) and examined during the course of the
infection. (B) Cells transfected with cDNA constructs expressing PTB-GFP and dsRED fused to 3 copies of the nuclear localization sequence of the SV40
large T-antigen (DsRED2-Nuc) were infected with FCV at a m.o.i. of 2. Cells were then examined over the course of the infection. See supplementary
files Figure S1 and Figure S2 for AVI data relating to A and B respectively.
doi:10.1371/journal.pone.0009562.g006
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(Fig 9a). The efficiency of RNase H in removing the genomic RNA
was assessed by in vitro translation of the digestion reaction in RRLs
(Fig 9b). The viral RNA treated with a non-specific oligonucleotide
produced a normal FCV protein profile, while the use of RdRp
specific oligonucleotide resulted in the elimination of all the viral
proteins encoded by the genomic RNA (Fig 9b). The FCV major
capsid protein is produced as a premature protein (LC-VP1) attached
to a leader polypeptide that is subsequently removed by the viral
protease, the NS6-7 protein. The absence of NS6-7 in the protein
profile is not only apparent directly by the lack of a radiolabeled
protein at the correct position in the gel, but also indirectly by the fact
that the LC-VP1 remained uncleaved in the in vitro translation
reactions (Fig 9b). The identity of the bands corresponding to the LC-
VP1 and the capsid in the FCV in vitro translation were verified by
immunoprecipitation using an a-VP1 antibody (Fig 9b). The RdRp
specific RNase H digested viral RNA was transfected into CRFK
cells treated with PTB or GFP specific siRNAs to assess the effect of
PTB knockdown on viral translation. As shown by western blot for
the capsid protein, the production of protein from the sgRNA was
greatly increased in the absence of PTB (Fig 9c). This suggests that
siRNA-mediated knockdown of PTB reduced the proposed
PTB-mediated inhibition in FCV translation resulting in increased
translation from the transfected sgRNA. It is interesting to note
however that the capsid protein that we detected had a similar
molecular weight to the mature major capsid protein that is present in
infected cells and virions (Fig 9c), while the premature LC-VP1
precursor protein, produced by the sgRNA in the absence of NS6-7,
was not detected. It has been reported previously that non-caliciviral
proteases are capable of processing LC-VP1 as maturation of VP1
and VLP production was observed when LC-VP1 was expressed in
CRFK cells and other cell lines when co-infected with Vaccinia virus
[44,45]. It is also possible that the production of an apparent mature
capsid cleavage product is the result of cleavage by cellular caspases,
induced as the result of multiple transfections, and previously known
to process the FCV capsid protein [46]. In addition, we cannot
formally exclude the possibility that very low levels of NS6-7 were
present due to small amount of genomic RNA not removed during
RNase H treatment.
Mutation of the PTB Binding Sites Results in a Cell Type
Specific Effect on FCV Replication
To further validate that PTB binding to the FCV genome plays
a role in the FCV life cycle, we examined the effect of synonymous
changes in the PTB binding sites on virus replication. Based on
our observation that PTB may negatively regulate FCV transla-
Figure 7. PTB colocalizes with mature FCV replication complexes in FCV infected CRFK cells. CRFK cells were infected with FCV for 16 h
at 32uC and at an m.o.i. of 0.5. (A) Infected cells were fixed and stained for NS6-7 (green) and PTB (DH17 monoclonal, red). DAPI was used for nuclei
(blue) staining. Note that only a fraction of the cytoplasm of an infected cell was observed using confocal microscopy. (B) Plot of pixel intensity for
NS6-7 and PTB along a straight line in the above image for the visualization of the colocalization of PTB with the replication complexes (NS6-7). A line
of quantification was arbitrarily drawn across the image (see insect picture for the position) and the staining intensity (arbitrary units) of NS6-7 and
PTB plotted against the pixel position (from left to right). Two replication complexes which contain both NS6-7 and PTB are highlighted in A and B.
(C) Viral RNA immunoprecipitation from FCV infected CRFK cells at 37uC with antibodies against PTB (DH17 and DH7) and the viral NS6-7. Antibody
for GAPDH protein was used as negative control and the NS6-7 IP was PCR amplified without reverse transcription to confirm the authenticity of
product (-RT). The presence of the viral RNA in immunoprecipitates was confirmed by RT-PCR amplification of nucleotide 1-245 of the FCV genome.
doi:10.1371/journal.pone.0009562.g007
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tion, we expected that reduced PTB binding might lead to an
inability to regulate translation and replication rates, resulting in
reduced virus titre. We therefore examined the growth of wild type
FCV and a strain containing synonymous mutations in BS2 and 3
within the 59 end of the viral genomic RNA (mBS2+3) in three
different cell lines; CRFK (feline kidney cell line), FEA (feline
embryonic airway) and AK-D cells (feline fetal lung). The effect of
mutations in the 59 end of the genomic RNA were examined as we
speculated that any alteration of the efficiency of translation and/
or replication of the viral genomic RNA, which encodes the
replicase components, would have a more apparent effect on virus
titre than similar mutations in the viral sgRNA, which encodes the
structural components only. Single step growth curve analysis
indicated that the mBS2+3 virus had a cell type specific defect in
virus replication, displaying reduced replication kinetics in the fetal
lung cell line AK-D (Fig 10a and b). A slight reduction in mBS2+3
titers was observed in CRFK and FEA cells at 6 hours post
infection as determined by titration of infectious virus produced
(Fig 10a). In AK-D cells however, a greater (.10 fold) reduction in
virus titre was observed when compared to the wild type virus
(Fig 10a). The decrease in mutant virus replication was more
apparent when low m.o.i. multi-cycle growth curves analysis were
performed (Fig 10b). At 8 hours post infection mBS2+3 displayed a
5.6, 8.3 and 14.7 fold reduction in CRFK, FEA and AK-D cells
respectively compared to WT virus. These data suggested that
PTB binding to the 59 end of the FCV genomic RNA is required
for optimal virus replication. Our analysis also indicated that in
vitro translation of mBS2+3 viral RNA was repressed to a lesser
degree by recombinant PTB than WT viral RNA (data not
shown). Hence the observed defect in replication is likely the result
of an inability to coordinate translation and replication. To further
elucidate the nature of the cell type specific effect and examine if
there was any correlation between the observed effects of the
binding site mutations and the levels of cellular PTB, we examined
the steady-state levels of PTB in the various cell lines using both
monoclonal and polyclonal antibodies (Fig 11a). We observed that
of the three cells lines examined, CRFK cells showed the lowest
levels of PTB expression, whereas AK-D and FEA cells appeared
to express comparable overall levels (Fig 11a). However, further
analysis by confocal imaging illustrated that whereas CRFK and
FEA cells displayed a somewhat uniform expression level between
the various cells within a culture, the AK-D population was very
heterogeneous (Fig 11b). There were clear examples of cells which
expressed high levels of PTB and also those in which PTB was
undetectable (circled in Fig 11a). This may be a reflection of the
cell cycle mediated regulation of PTB as PTB transcripts have
Figure 8. PTB inhibits FCV translation in vitro. (A) Effect of his-PTB on FCV in vitro translation that demonstrates the reduced expression of FCV
proteins produced by the translation of ORF1 (from the genomic RNA) and ORF2 (from the subgenomic RNA). The 35S methionine labeled FCV
proteins were analyzed by SDS-PAGE. Addition of increasing amounts of in vitro transcribed RNA encompassing nucleotides 1–245 of the FCV
genome (59G1-245) led to the recovery of the FCV translation. The bar chart illustrates the efficiency of FCV translation as percentage of the control
(0 ng PTB) as measured by phosphorimager quantification. The poliovirus protease-polymerase 3CD was used to control for any non-specific effects
of adding recombinant protein to the reaction. Error bars represent the standard deviation from three different experiments. (B) Increasing amounts
of his-PTB and 59G 1-245 in the in vitro translation of a dicistronic RNA construct that expressed the CAT enzyme under the cap structure and firefly
luciferase under the FMDV IRES. The 35S methionine labeled CAT and firefly luciferase were analyzed by SDS-PAGE. The bar chart illustrates the
efficiency of cap- and FMDV IRES-dependent translation as a percentage of the control (0ng PTB) as measured by phosphorimager quantification.
Error bars represent the standard deviation from three different experiments.
doi:10.1371/journal.pone.0009562.g008
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been reported to be induced in the S and G2M phase of certain
cell types [47]. Hence this variation in PTB levels may in some
way contribute to the cell type specific effect on the growth of the
mBS2+3 recombinant virus, again highlighting that PTB expres-
sion and binding plays an important role in the regulating the
efficiency of virus translation and replication.
Discussion
Our previously published data revealed that PTB was required
for the efficient replication of FCV, as siRNA mediated
knockdown of the protein significantly reduced the virus yield in
CRFK cells [34]. During positive-strand RNA virus replication
genome translation is linked to viral genome replication, hence
any effects on translation have knock-on effects on replication and
vice versa. Thus, the reduction in FCV virus replication and
subsequent yield of infectious virus that we previously observed
upon PTB knockdown could not be attributed to one specific
function of PTB within the viral life cycle.
Previous studies have highlighted that the primary role for PTB
in the life cycle of several positive-strand RNA viruses is at the
level of viral translation, primarily functioning as an enhancer of
translation initiation [14,48]. It is believed that the stabilization of
a functional RNA structure or conformation of the viral IRES by
PTB modulates the association of the IRES with the translation
machinery [49,50]. However picornavirus protease mediated
cleavage of PTB is also thought to result in the inhibition of
translation, promoting a switch from translation to replication
[51]. Although PTB is known to act as a translation enhancer, a
recent report demonstrated a repressive role for PTB on the
translation of the Oskar protein in Drosophila, highlighting that the
action of any RNA-binding protein largely depends on the RNP
that it is a component of [52]. Studies have also shown that PTB
interacts with the 59 and 39 ends of the Norwalk virus genome and
although the function of this interaction has yet to be determined
[53,54], recent work has highlighted that the 59 and 39 ends of the
Norwalk virus genome interact via binding to host cell proteins to
form an RNP [55], of which PTB may be a component.
This study was designed to try to address the fundamental role of
PTB in the calicivirus life cycle using feline calicivirus as a model
system. Prior to this study, the only available system to allow the
examination of FCV translation, in the absence of genome
replication was the in vitro RRL translation system [31]. Using this
system we demonstrated that PTB may function as a negative
regulator of FCV translation (Fig 8), as is the case for the Drosophila
Oskar protein. During these studies we found that although at low
levels of exogenous PTB, a limited increase of the FMDV IRES
activity in vitro was observed, higher levels led to a significant
Figure 9. RNAi mediated knockdown of PTB inhibit the translation from the FCV subgenomic RNA in cells. (A) Genome schematic of
the FCV genome highlighting the position of the three FCV open reading frames and the NS6-7 specific primer which bound to nucleotides between
3215–3244 used for RNase H-directed inactivation of the FCV genomic RNA. (B) In vitro translation of FCV RNA after RNase H digestion using an FCV
genomic RNA specific DNA oligonucleotide (FP) and a control DNA oligonucleotide (CP). Immunoprecipitation (VP1-IP) with a-major capsid (VP1)
from the in vitro translation of FCV RNA after RNase H digestion using an FCV genomic RNA specific DNA oligonucleotide and a control DNA
oligonucleotide. The proteins were labeled with 35S methionine and the SDS-PAGE analysis was exposed to a phosphorimager screen. (C) Western
blot for the major capsid protein (VP1) in infected CRFK cells, purified virus, non-transfected CRFK cells and CRFK cells treated with PTB or GFP siRNAs
that have been transfected with FCV RNA digested with RNase H using an FCV specific DNA oligonucleotide. Control blots for PTB and GAPDH are
shown to demonstrate PTB knockdown and equal loading of samples. Results displayed were obtained from cells incubated at 37uC but identical
results were also observed when the experiments were performed at 32uC (data not shown) An asterisk is used to highlight a non-specific protein
with reactivity to anti-VP1 antisera.
doi:10.1371/journal.pone.0009562.g009
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reduction, presumably through the titration of additional factors.
The original investigations into the involvement of PTB in FMDV
translation, revealed that dependence on PTB was observed only in
RRLs depleted of PTB [13]. Work on PTB depleted RRLs showed
that absence of PTB did not affect FCV translation, while FMDV
translation was significantly reduced (data not shown). In our
previous work, PTB knockdown had a temperature-dependent
effect on FCV replication, which may reflect a higher requirement
for the RNA chaperone activity of PTB at temperatures where
RNA folding is sub-optimal [34]. Thus, we also assessed how the
inhibitory effect of PTB varied at different temperatures, despite the
fact that the optimal temperature range for in vitro translation is
significantly lower than the temperature for the normal virus
infection. The inhibitory effect of PTB was more apparent at
temperatures lower or higher than the optimal 30uC (data not
shown) providing additional evidence towards the RNA chaperone
activity of PTB under suboptimal conditions.
Due to the unique mechanism of calicivirus translation, an
attempt to verify the role of PTB in FCV translation in cell culture
was made by selective digestion of the genomic RNA in the mixture
of viral RNAs using RNase H. The inactivation of the genomic
RNA allowed only translation from the sgRNA that, in the absence
of polymerase, cannot be replicated. It is known that both genomic
and subgenomic RNA are translated by the same VPg-dependent
mechanism [29] and given our previous observations that PTB also
binds the sgRNA [34] we examined the effect of PTB knockdown
on viral RNA translation in the absence of replication. The
translation of the sgRNA in CRFK cells, as determined by VP1
expression, was significantly increased under low levels of PTB
(Fig 9), confirming a repressive role of PTB on viral translation in
cells. Surprisingly our results indicated that the capsid precursor
protein LC-VP1was processed into the mature form of VP1 (Fig 9c).
Previous reports have highlighted that infection of cells with Vaccinia
virus can result in the processing of the FCV LC-VP1 into the
mature VP1 protein [44,45]. This may have been either due to a
Vaccinia virus encoded protease or the induction of a cellular stress
leading to the expression of a protease responsible for the observed
processing. It is therefore possible that the multiple transfections
required to obtain efficient PTB knockdown, followed by
subsequent transfection with viral sgRNA also resulted in the
induction of a similar cellular stress related protease which
processed LC-VP1 to produce a protein of approximately the same
mass as the mature capsid protein. Indeed previous studies have
highlighted that caspase 2 induced during FCV infection can cleave
the mature capsid protein (60kDa) during FCV infection to produce
a ,40kDa product [46]. Therefore caspase mediated cleavage of
the premature protein (73kDa) might produce a ,53kDa product,
which may in fact be the product observed during our studies
Figure 10. Mutations in PTB binding sites 2 and 3 results in a cell type specific defect in FCV replication. (A) Single and multi-cycle (B)
growth curve analysis of wild type FCV Urbana strain derived from cDNA (WT) or a derivative carrying synonymous nucleotide changes in PTB binding
sites 2 and 3 at the 59 end of the genomic RNA. Cells were infected with a m.o.i. of 3 for single-cycle and 0.01 for multi-cycle (based on the titre of viral
stocks in CRFK cells) and samples harvested at various times post inoculation. Viral titre was subsequently determined by TCID50 on CRFK cells and
expressed as TCID50 per ml. Infections were performed in triplicate and the error bars represent the standard deviation. *** P,0.001 *P,0.01
*P,0.05 by two-way ANOVA.
doi:10.1371/journal.pone.0009562.g010
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(Fig 9c). It is also possible that whilst we were unable to detect any
NS6-7 protease in cells transfected with the sgRNA preparations
(data not shown), we cannot rule out that a very small amount of this
highly processive enzyme was expressed from low levels of viral
genomic RNA not removed by the RNase H digestion. Despite this,
the interpretation of our data i.e. that PTB knockdown stimulates
viral translation, remains valid.
At first glance the increased levels of viral sgRNA translation in
PTB depleted CRFK cells is contrary to our previously observed
reduced viral replication (observed at both protein and viral RNA
levels) [34]. However, it is important to note that the genomes of
positive-strand RNA viruses functions for both translation and
replication, hence any interference with one step will have a
concomitant effect on the other. It has previously been
demonstrated that actively translating ribosomes can efficiently
inhibit poliovirus RNA synthesis [56] and that the interaction of
the viral polymerase precursor 3CD with the 59 end, in
combination with the cellular protein PCBP2, inhibits translation
promoting negative strand RNA synthesis [57]. At the initial stages
of infection it is crucial for the infecting virus to transform the
intracellular environment in order to achieve efficient replication
[43]. This occurs by translation of the viral RNA to produce the
proteins required for the rearrangement of the cellular membra-
nous structures which lead to the formation of the replication
complexes [58]. As the microenvironment of each replication
complex becomes saturated with viral proteins, translation is
decelerated to favor the production of new viral RNAs. This
switch between translation and replication must occur as the
RdRp proceeds in a direction opposite to the ribosome during
negative-strand RNA synthesis. The involvement of PCBP2 in
the switch between translation and replication in polioviruses
highlights the importance of host-cell RNA binding proteins in this
process [57]. It is possible that PTB, through interaction with the
calicivirus RNA, and possibly in combination with other viral or
cellular proteins, PTB decreases the translation rate by sequestra-
tion of the 59 extremity from the translational machinery. The
result is the formation of an RNP, of which PTB is a component,
which promotes replication at the later stages of the virus life cycle.
Cleavage of PTB and PABP has also been suggested as possible
mechanisms of controlling the switch between picornavirus
genome translation and replication [51,59]. Our analysis would
indicate that no stable PTB cleavage products are visible in FCV
infected cells [34], however the previously described cleavage of
PABP mediated by both Norwalk and FCV protease may also
contribute to any potential switch in translation and replication
[60]. It is worth noting however that although calicivirus genomes
possess a poly(A) tail, a direct role for PABP in calicivirus
translation has yet to be demonstrated. In addition, PABP
cleavage was observed only at late stages of FCV infection, where
most viral replication has already taken place and viral titres
approach their maximal level (see Fig 10a). It is therefore likely
that PABP cleavage may serve primarily to reduce host cell protein
synthesis, promoting cell death and virus release, although clearly
further studies to address this are warranted.
As PTB is predominantly nuclear, our observed cytoplasmic
relocalization during FCV infection would add to our hypothesis
on the involvement of PTB in the maturation of the viral
replication complexes. It is noteworthy that only partial coloca-
lization of PTB with NS6-7 was observed during our study (Fig 7a).
Whilst this may indicate that much of the NS6-7 is not actively
engaged in viral genome replication, it may also indicate that PTB
is present only in ‘‘mature’’ replication complexes which are no
longer translating viral genomes but are actively engaged in viral
genome replication. In addition, we cannot rule out the possibility
that this lack of complete colocalization is not simply the result of
lack of accessibility of the PTB mAb epitope within many of the
membrane bound replication complexes. Our real-time analysis of
the effect of virus infection, clearly demonstrated that PTB
redistribution to the cytoplasm occurs prior to any global effect on
nuclear-cytoplasmic shuttling (Fig 6). It is now well established that
nuclear factors important for viral replication, such as PTB,
translocate from the nucleus to the cytoplasm during poliovirus
Figure 11. Characterisation of PTB distribution and expression levels in various cell types. (A) Western blot and (B) confocal image
analysis of the expression and cellular distribution of PTB in uninfected AK-D, CRFK and FEA cells. Approximately 16105 cells were lysed and analysed
by western blot using both monoclonal (DH17) and polyclonal (N20) antibodies to PTB (A). GAPDH was used to ensure equal loading. (B) Confocal
analysis of AK-D, CRFK and FEA cells stained for DNA with DAPI (blue) and PTB (DH17 monoclonal, green). L, M and H highlight AK-D cells expressing
low, medium and high levels of PTB respectively. Size bar represents 100 mm.
doi:10.1371/journal.pone.0009562.g011
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[7], rhinovirus [61] and dengue virus [6] infection. In some cases
the mechanism of this relocation has been linked to an observed
modification of the components of the nuclear pore [7,61]. The
observation that, in addition to the specific effect on PTB
localization, FCV infection also has a more general effect on the
import of proteins containing an NLS (Fig 6b), may indicate that
FCV also modifies the nuclear pore in some way. It is possible that
virus induced apoptosis is responsible as caspases have been
reported to cleave nucleporins [62], although whether this occurs
during FCV infection will require further verification.
The cell type specific effect of the PTB binding site mutations is
somewhat intriguing and may be due to the apparent heteroge-
neity of PTB expression in AK-D cells (Fig 11b). Previous reports
have highlighted that PTB transcripts can to be induced in the S
and G2M phase of certain cell types [47] but whether this is the
case in AK-D cells remains to be determined. It is well established
that variations in the expression of PTB and PTB isoforms can
result in cell type specific effects on RNA viruses [63]. It is also
possible that in addition to PTB, the cell type specific variation in
expression of other, as yet unidentified cellular factors which
function as part of the PTB-containing RNP, also contributes to
the observed effect on FCV replication. The identification of these
factors is currently the focus of ongoing studies.
In light of these data, we propose a speculative model for the
function of PTB in the FCV life cycle detailed in figure 12. During
the early stages of FCV infection translation occurs in the
cytoplasm of infected cells producing the various viral proteins
(Fig 12a). As the levels of viral proteins accumulate, a specific
modification of the nuclear-cytoplasmic shuttling of PTB occurs
(Fig 12b) causing PTB to translocate from the nucleus to the
cytoplasm (Fig 12c) to form an RNP complex at the 59 end of the
viral RNA (Fig 12d). PTB binding to the 59 end, probably in
combination with other host cell or viral factors, prevents
translation initiation and ribosome recruitment (Fig 12d) promot-
ing the synthesis of viral RNA (Fig 12e). The above findings
support a role for the first RNA-binding protein to be identified as
part of a functional calicivirus RNP complex and give further
insight in the molecular mechanism used for genome translation
and replication by this important group of pathogens.
Supporting Information
Figure S1 Time-lapse analysis of the effect of FCV infection on
PTB localization. GFP-PTB expressing CRFK cells were infected
with recombinant FCV expressing a LC-dsRED fusion protein
(m.o.i. 2) and examined during the course of the infection. XVID
file.
Found at: doi:10.1371/journal.pone.0009562.s001 (1.01 MB AVI)
Figure S2 Time-lapse analysis of the effect of FCV infection on
nuclear localization. Cells transfected with cDNA constructs
expressing PTB-GFP and dsRED fused to 3 copies of the nuclear
localization sequence of the SV40 large T-antigen (DsRED2-Nuc)
were infected with FCV at a m.o.i. of 2. Cells were then examined
over the course of the infection. XVID File.
Found at: doi:10.1371/journal.pone.0009562.s002 (1.38 MB AVI)
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